Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Pleural Mesotheliomas

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Besançon - CHU, Besançon, France

  • Brest - CHU, Brest, France

  • Caen - CHU, Caen, France

  • Clermont-Ferrand - Centre Jean Perrin, Clermont-Ferrand, France

  • Créteil - CHI, Créteil, France

  • Grenoble - CHU, Grenoble, France

  • Le Mans - CHG, Le Mans, France

  • Lille - CHU, Lille, France

  • Marseille - APHM, Marseille, France

  • Montpellier - CHU, Montpellier, France

  • Mulhouse - GHRMSA, Mulhouse, France

  • Nantes - Hôpital Laennec, Nantes, France

  • Paris - Bichat, Paris, France

  • Bordeaux - CHU, Pessac, France

  • Lyon - HCL, Pierre-Bénite, France

  • Strasbourg - Nouvel Hôpital Civil, Strasbourg, France

  • Toulon - CHI, Toulon, France

  • Toulouse - CHU, Toulouse, France

  • Tours - CHU, Tours, France

  • Metz - Hôpital Robert Schuman, Vantoux, France